ESMO Media Releases

The ESMO President for the 2018-2019 period will be Josep Tabernero

The scale offers a rational, structured and consistent approach to ‘stratify’ a drug’s clinically meaningful benefit

To mark the European Week against Cancer, ESMO is highlighting positive developments and challenges to come from the EU's Clinical Trials Regulation

Circulating tumour DNA in blood a valid option for EGFR testing in patients who do not have accessible tumour tissue, study shows

Lack of test results may impact treatment effectiveness and survival, survey in Europe, Asia and US reveals

Survey shows that many live in ‘denial’ of the real risks of smoking even a small number of cigarettes a day

Many patients with BRAF-mutant cancers benefit from treatment with BRAF inhibitors, European researchers report at ELCC

The award will be presented at the European Lung Cancer Conference (ELCC) 2015, held 15 to 18 April in Geneva, Switzerland

A course dedicated to educating the next generation of oncologists about the essentials of clinical trial design, implementation, and analysis, will be organised this week by ESMO

On World Cancer Day 2015, ESMO acknowledges patient’s right to access treatment and highlights collaborative efforts towards improving access for all

New website section dedicated to research funding opportunities created to promote and improve clinical cancer research in Europe